ABC
XLRN

Associated Banc-Corp’s Acceleron Pharma XLRN Stock Holding History

Associated Banc-Corp’s Portfolio XLRN Stock Details XLRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-28
Closed -$4K – 972
2020
Q4 		$4K Hold
28
– – ﹤0.01% 591
2020
Q3 		$3K Hold
28
– – ﹤0.01% 612
2020
Q2 		$3K Hold
28
– – ﹤0.01% 583
2020
Q1 		$3K Buy
+28
New +$2.18K ﹤0.01% 503

Other funds holding XLRN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Associated Banc-Corp's XLRN Position: Q1 2021 in Review

Associated Banc-Corp sold out of Acceleron Pharma (XLRN) in Q1 2021, closing a stake of 28 shares — an estimated $4K sold.

Associated Banc-Corp first reported a position in XLRN in Q1 2020 and held it in 4 quarters. The position peaked at $4K in Q4 2020. 256 funds tracked by Wall St. Rank hold XLRN as of Q1 2021.

  • Associated Banc-Corp reported no remaining Acceleron Pharma position as of Q1 2021 after selling out during the quarter.
  • Associated Banc-Corp sold 28 Acceleron Pharma shares in Q1 2021, an estimated $4K.
  • Associated Banc-Corp first reported a position in Acceleron Pharma in Q1 2020 and held it in 4 quarters.
  • Associated Banc-Corp's Acceleron Pharma position peaked at $4K in Q4 2020.
  • 256 funds tracked by Wall St. Rank held Acceleron Pharma as of Q1 2021.

Based on Associated Banc-Corp's 13F filing for Q1 2021, filed 5 May 2021.